PU1 Transcription Factor and Osteoclastogenesis

Agency: National Institute of Health (NIH)
Institute: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 1R29AR044089-01
Application #: 2083826
Study Section: Orthopedics and Musculoskeletal Study Section (ORTH)


NIH 2000 R29 AR	PU1 Transcription Factor and Osteoclastogenesis Tondravi, Mehrdad M. / American National Red Cross	$117,208
NIH 1999 R29 AR	PU1 Transcription Factor and Osteoclastogenesis Tondravi, Mehrdad M. / American National Red Cross
NIH 1998 R29 AR	PU1 Transcription Factor and Osteoclastogenesis Tondravi, Mehrdad M. / American National Red Cross
NIH 1997 R29 AR	PU1 Transcription Factor and Osteoclastogenesis Tondravi, Mehrdad M. / Barnes-Jewish Hospital
NIH 1996 R29 AR	PU1 Transcription Factor and Osteoclastogenesis Tondravi, Mehrdad M. / Barnes-Jewish Hospital

Wang, Ruoxiang; Zhang, Liying; Zhang, Xiaoren et al. (2002) Regulation of activation-induced receptor activator of NF-kappaB ligand (RANKL) expression in T cells. Eur J Immunol 32:1090-8

Li, B; Boast, S; de los Santos, K et al. (2000) Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 24:304-8